Whether maintenance therapy is needed after chemoimmunotherapy and remission really depends on the specific type of lymphoma and individual circumstances — it's not a one-size-fits-all answer.
For some types of lymphoma, like follicular lymphoma, maintenance therapy (often rituximab) may be recommended after initial Show Full Answer
Whether maintenance therapy is needed after chemoimmunotherapy and remission really depends on the specific type of lymphoma and individual circumstances — it's not a one-size-fits-all answer.
For some types of lymphoma, like follicular lymphoma, maintenance therapy (often rituximab) may be recommended after initial treatment. It's typically given once every few months for up to two years. The goal is to:
- Help eliminate any remaining cancer cells
- Slow down or prevent cancer from growing back
- Extend the period of remission For more aggressive types like diffuse large B-cell lymphoma (DLBCL), maintenance therapy isn't always standard after achieving remission. Many patients who respond well to treatment stay in remission without it.
The most important thing is to have an open conversation with your oncologist about whether maintenance therapy is right for your specific situation. They'll consider your lymphoma type, how well you responded to treatment, and your overall health.
Regular follow-up appointments remain crucial regardless, so any signs of relapse can be caught early.
5 days ago
Join
Your Privacy Choices
